Introduction Dyspnoea is a major barrier to effective pulmonary rehabilitation in patients with chronic obstructive pulmonary ...
Association of pulmonary artery radiation with pulmonary hypertension after lung cancer radiotherapy
Background Thoracic radiotherapy (RT) results in pulmonary fibrosis that has been hypothesised to increase the risk of ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
For many patients with chronic obstructive pulmonary disease (COPD), the greatest threat to survival may arise not from respiratory failure but from cardiovascular disease. COPD is increasingly ...
Background In most chronic airway diseases, identifying phenotypes has advanced clinical practice and research. However, no such phenotypes exist for paediatric bronchiectasis. We therefore sought to ...
A 62-year-old man with a history of systemic Amyloid light-chain (AL) amyloidosis in prior haematological remission presented with progressive dyspnoea and non-productive cough. He denied haemoptysis, ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Background Disease modifying therapies for progressive fibrotic interstitial lung diseases (F-ILDs) slow physiological decline but have not consistently shown to improve patient-reported symptoms or ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Establishing the top 10 research priorities for lung volume reduction treatment for people with COPD
Lung volume reduction procedures are an established evidence-based aspect of chronic obstructive pulmonary disease (COPD) care. We conducted a research prioritisation exercise involving people with ...
Acute asthma exacerbations remain a major driver of morbidity and hospitalisation, accounting for substantial healthcare utilisation worldwide. Systemic oral corticosteroids (OCS) are the first-line ...
Can targeted combination pharmacotherapy find its mark in the treatment of obstructive sleep apnoea?
The search for an effective drug therapy for obstructive sleep apnoea (OSA) has long been driven by a familiar clinical reality: although positive airway pressure (PAP) remains highly efficacious, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results